Tag: NASDAQ:RARE

In a filing, Ultragenyx Pharmaceutical Inc revealed its President & CEO KAKKIS EMIL D unloaded Company’s shares for reported $0.41

In a filing, Ultragenyx Pharmaceutical Inc revealed its Officer KAKKIS EMIL D acquired Company’s shares for reported $0.41 million on

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ultragenyx Pharmaceutical

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Ultragenyx Pharmaceutical Inc’s recent filing unveils that its Chief Financial Officer Horn Howard unloaded Company’s shares for reported $0.39 million